QUOTE AND NEWS
newratings.com  Jul 15  Comment 
BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution BB Biotech AG / BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act)...
newratings.com  Jul 14  Comment 
BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution BB Biotech AG / BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim...
newratings.com  Jul 11  Comment 
BB Biotech AG with after-tax loss in the first half year of 2016 BB BIOTECH AG / BB Biotech AG with after-tax loss in the first half year of 2016 . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for...
newratings.com  Jun 30  Comment 
ADVA Optical Networking SE : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution ADVA Optical Networking SE / ADVA Optical Networking SE : Publication pursuant to §26a WpHG (the...
Motley Fool  Jun 27  Comment 
Post-Brexit interest rate concerns appear to be weighing on the company's share price.
newratings.com  Jun 23  Comment 
BB Biotech AG :Release of the Home Member State according to Article 2c of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution BB Biotech AG / BB Biotech AG :Release of the Home Member State according to...
newratings.com  Jun 14  Comment 
MorphoSys AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution MorphoSys AG / MorphoSys AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act)...
newratings.com  Jun 9  Comment 
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) MorphoSys AG / Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) . Processed and transmitted by...
newratings.com  Jun 6  Comment 
Bellevue Group has completed its acquisition of StarCapital AG - further steps to expand the business being taken together Bellevue Group AG / Bellevue Group has completed its acquisition of StarCapital AG - further steps to expand the business...




 
TOP CONTRIBUTORS

Genworth Financial (NYSE: GNW) provides domestic and international mortgage insurance, long-term care insurance, and life insurance products. Genworth's exposure to some of the recently maligned companies (like Fannie Mae (FNM), Freddie Mac (FRE), American International Group (AIG), Lehman Brothers (LEH), and Washington Mutual (WM)) totals roughly $630 million.[1]

In February 2008, Genworth reported a $93 million write-down due to underestimated risk in its actuarial models as well as losses due to investments in subprime securities.[2] Over the past year, Genworth's stock has steadily fallen from a high of 31.77 per share to a low of 4.85 per share as of September 29, 2008.[3]

That said, the company has maintained its "AA" credit rating while many of its competitors have been reduced to "A" ratings.[4] It maintains approximately $800 million in cash and has a roughly $1.8 billion credit facility available.[5] The company has even continued to issue a $0.10 quarterly dividend.[6]




References

  1. "Genworth says it may spin off its mortgage insurance business, MarketWatch, September 30, 2008
  2. "Zacks Industry Rank Analysis Highlights: AIG, FLIR, GNW, LNC, and NOC", BNET, February 14, 2008
  3. Google Finance GNW Page
  4. "Deutsche Bank analyst: Genworth well-capitalized", Forbes, September 26, 2008
  5. "Conseco shares slump 40% on exposure to AIG, Lehman, WaMu, ShareBuilder, September 17, 2008
  6. Reuters Key Development GNW
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki